Turnover
≈ €1.6m estimated
The accounts state no turnover.
Pharmacie Pharmavie Gilly
Information for creditors
Enterprise Court of Hainaut · Official Gazette of 02-10-2023Steps, deadlines and articles of law
The procedure
- Official Gazette
- 02-10-2023search the document for 2023/136002
Steps for a creditor
- Do not attach assets or start enforcement for debts from before the opening while the moratorium runs.
- How you are paid depends on the track of the reorganisation: an amicable settlement, a collective agreement with a plan the creditors vote on, or a transfer. The judgment and RegSol say which.
- What you deliver after the opening is not covered by the moratorium. Agree clear payment terms for it.
- The file is in RegSol, where you can read the documents of the procedure.
The judgment sets how long the moratorium runs. That date is in RegSol and in the publication in the Official Gazette.
Your claim still exists, but while the moratorium runs you cannot enforce it. What you do now depends on the track of the reorganisation.
Follow
Follow this reorganisation and you are notified of an extension, the court's approval, the closure or a bankruptcy.
This is general information, not legal advice. If in doubt, your lawyer or your accountant can help.
Embed in an article
Embed the Pharmacie Pharmavie Gilly company card in your article about this reorganisation: name, enterprise number, its status in the KBO and the latest annual accounts, with a link to this dossier.
Preview
The preview appears here.
- The card stays current. The status follows the register and the figures come from the latest filed accounts. It carries no Checked score or verdict.
- It barely adds weight to your page: one small script and one data request, also answered from a cache. There are no cookies and no tracking.
- Where scripts do not run (a newsletter, a feed reader) a plain link remains.
Lifetime
17 annual accounts with figures on one time axis, 19 filings since 2004peak €447,868 (2025)
€447,868▲ 71.1%
lowest -€16,428 (2023)
€18,111▼ 30.8%
peak €255,651 (2021)
€220,956▲ 8.9%
€292,502▲ 47.0%
peak 3.1 FTE (2025)
3.1 FTE▲ 19.2%
Board4 names since 2022
1 directorSRL BLONDEAU-VANDER CASSYEN
Owners
Documentsfilings and deeds
31-08-202631 days late
2025abbreviated format
Court officer appointed 13-02Gross margin from €261,793 to €447,868Result from €26,184 to €18,111Staff from 2.6 FTE to 3.1 FTECompany renamed from PHARMACIE TERGOLINA to Pharmacie Pharmav… 07-04Resignations: Michaël WILLEMS (director) and Didier PETRE (ma… 12-03
Key points
from the 2025 annual accountsDebts
€292,502 ▲ 47.0%
Debts rose by €93,502 in 2025.
Filings
19 annual accounts since 2004
Five of the last ten came late. The 2023 accounts came latest: 42 days after the end of the period.
Reorganisation running: about 1 in 4 bankrupt within the year
Checked score
24
Critical
Without a bankruptcy probability, the score rests on the figures alone.
An ongoing judicial reorganisation from the Belgian Official Gazette caps the score at 24.
Bankruptcy probability within 12 months
Judicial reorganisation
About 1 in 4 comparable companies went bankrupt within the year
A judicial reorganisation is open. There is then no bankruptcy probability from the figures. Of every Belgian company in an open or failed reorganisation, 25% to 26% went bankrupt within twelve months (measured in 2024 and 2025).
Financial strengthAverage
Credit verdict
No credit on open account during an ongoing judicial reorganisation
Liquidity is tight, with a current ratio of 1.3 (1.19 in 2024), below the usual 1.5. Short-term debt is 57% and cash 7.9% of total assets. 57% of the assets are financed with debt and provisions.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Two signals.
raises risk
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
31 days late
2024
20 days early
2023
42 days late
2022
2 days late
2021
3 days early
2020
27 days late
2019
36 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 6 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (1)
Board and ownership
- PHARMACIE BLONDEAU - VANDER CASSYEN 100%score 89equity €1.3m (2025) · 2025 annual accounts of PHARMACIE BLONDEAU - VANDER CASSYEN
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0478753891
Company renamed from PHARMACIE TERGOLINA to Pharmacie Pharmavie Gilly
General meeting of 31-03-2025 · Gazette deed
Resignations: Michaël WILLEMS (director) and Didier PETRE (managing director)
Marie-Christine TERGOLINA is a shareholder · Daniel ROELANDT is a shareholder · PHARMASIMPLE is a shareholder · General meeting of 31-01-2025 · Gazette deed
Appointment: SRL BLONDEAU-VANDER CASSYEN (director)
Permanent representative: Virginie VANDER CASSYEN · Director discharge: Francis BRINGARD (praticien de la réorganisation judiciaire) · General meeting of 18-02-2025 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Pharmacie Pharmavie Gilly Charleroi | €513,458 | €447,868 | 43.0% | 3.1 |
| Geassocieerde Apotheek Merelbeke Merelbeke-Melle | €588,299 | €396,190 | 14.7% | 3.8 |
| PHARMACIE GANSER Villers-le-Bouillet | €616,588 | €366,407 | 51.3% | 3.1 |
| APOTHEEK STORME Merelbeke-Melle | €544,138 | €368,689 | 58.1% | 3.7 |
| PHARMACIE MERTENS Estaimpuis | €736,434 | €369,729 | 56.5% | 2.9 |
| PHARMA JACK Charleroi | €604,334 | €375,987 | 9.2% | 4.5 |
| PHARMACIE LAPERCHE Evere | €485,699 | €330,897 | 42.7% | 2.7 |
These companies have the same main activity as Pharmacie Pharmavie Gilly: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €486,000 and €736,000, founded between 2001 and 2006.
Official details
Source: KBO- Status
- Active since 12-11-2002Judicial reorganisation · normal situation in the KBO register
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 1 other
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.115.184.4736060 Charleroi, since 09-12-2002
- Financial year end
- 31 December
- Peppol
- Reachable since 11-12-2025
Insights on Pharmacie Pharmavie Gilly
Pharmacie Pharmavie Gilly files the abbreviated format. That format states no turnover. The gross margin rose from €97,990 in 2007 to €447,868 in 2025.
PHARMACIE BLONDEAU - VANDER CASSYEN holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Pharmacie Pharmavie Gilly
- What is the company number of Pharmacie Pharmavie Gilly?
- The company number of Pharmacie Pharmavie Gilly is 0478.753.891. The VAT number is the same number with BE in front: BE 0478.753.891.
- Where is Pharmacie Pharmavie Gilly based?
- The registered office is at Rue Noir Dieu 9, 6060 Charleroi.Company details
- What does Pharmacie Pharmavie Gilly do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Pharmacie Pharmavie Gilly?
- Pharmacie Pharmavie Gilly is a private limited company (BV).
- When was Pharmacie Pharmavie Gilly founded?
- Pharmacie Pharmavie Gilly was founded on 12-11-2002.
- Is Pharmacie Pharmavie Gilly still active?
- Yes, Pharmacie Pharmavie Gilly is in the KBO register. A judicial reorganisation is running.
- How many employees does Pharmacie Pharmavie Gilly have?
- Pharmacie Pharmavie Gilly had an average of 3.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does Pharmacie Pharmavie Gilly fall under?
- In its 2025 annual accounts, Pharmacie Pharmavie Gilly states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of Pharmacie Pharmavie Gilly?
- The turnover in financial year 2025 is ≈ €1.6m. This figure is estimated from the gross margin of €447,868 and 47 comparable companies (NACE 477). It probably lies between €1.2m and €2.5m. In financial year 2019 turnover was €920,717.
- Is Pharmacie Pharmavie Gilly profitable?
- In financial year 2025, Pharmacie Pharmavie Gilly made a profit of €18,111.
- Where can I find the annual accounts of Pharmacie Pharmavie Gilly?
- Pharmacie Pharmavie Gilly filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
Next steps
Check what to know before you do business with this company.Supplier due diligence See this company's board, registered office and name on a given date.Company as of a date Check whether the registered address is a letterbox address or a business centre.Addresses Check your own customer list for customers at risk.Process a list See how the retail sale of pharmaceutical products sector is doing.Sector figures